Clinical Trials Browser

Phase 2 × Iloprost × Clear all

NCT05411107 2024-05-17

Oral Iloprost for the Prevention of Lung Cancer In Former Smokers

Phase 2 Withdrawn

Lung Neoplasms, Pulmonary Disease, Chronic Obstructive

NCT00084409 2020-05-14

Iloprost in Preventing Lung Cancer in Patients at High Risk for This Disease

Phase 2 Completed

152 enrolled 18 charts

Other neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Precancerous Conditions